Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 460

1.

Knowledge, attitudes and practices on tuberculosis transmission and prevention among auxiliary healthcare professionals in three Brazilian high-burden cities: a cross-sectional survey.

Trajman A, Wakoff-Pereira MF, Ramos-Silva J, Cordeiro-Santos M, Militão de Albuquerque MF, Hill PC, Menzies D.

BMC Health Serv Res. 2019 Jul 30;19(1):532. doi: 10.1186/s12913-019-4231-x.

2.

Multidrug-resistant tuberculosis - Authors' reply.

Menzies D, Benedetti A, Migliori GB, Nahid P, Seaworth B.

Lancet. 2019 Jul 27;394(10195):299-300. doi: 10.1016/S0140-6736(19)30692-0. No abstract available.

PMID:
31354139
3.

New prebiotic chemistry inspired filter media for stormwater/greywater disinfection.

Jung J, Menzies DJ, Thissen H, Easton CD, Evans RA, Henry R, Deletic A, McCarthy DT.

J Hazard Mater. 2019 Jun 7;378:120749. doi: 10.1016/j.jhazmat.2019.120749. [Epub ahead of print]

PMID:
31226585
4.

Differential functionalisation of the internal and external surfaces of carbon-stabilised nanoporous silicon.

Alba M, Robin M, Menzies D, Gengenbach TR, Prieto-Simon B, Voelcker NH.

Chem Commun (Camb). 2019 Jul 4;55(55):8001-8004. doi: 10.1039/c9cc03755a.

PMID:
31225547
5.

Paraneoplastic phenomenon in mesothelioma.

Waqar AB, Menzies D, Casey M, Doran M.

Thorax. 2019 Jul;74(7):719-720. doi: 10.1136/thoraxjnl-2019-213176. Epub 2019 May 20.

PMID:
31110054
6.

Analysis of loss to follow-up in 4099 multidrug-resistant pulmonary tuberculosis patients.

Walker IF, Shi O, Hicks JP, Elsey H, Wei X, Menzies D, Lan Z, Falzon D, Migliori GB, Pérez-Guzmán C, Vargas MH, García-García L, Sifuentes Osornio J, Ponce-De-León A, van der Walt M, Newell JN.

Eur Respir J. 2019 Jul 11;54(1). pii: 1800353. doi: 10.1183/13993003.00353-2018. Print 2019 Jul.

PMID:
31073080
7.

Rates and timeliness of treatment initiation among drug-resistant tuberculosis patients in Nigeria- A retrospective cohort study.

Oga-Omenka C, Zarowsky C, Agbaje A, Kuye J, Menzies D.

PLoS One. 2019 Apr 25;14(4):e0215542. doi: 10.1371/journal.pone.0215542. eCollection 2019.

8.

The mTST - An mHealth approach for training and quality assurance of tuberculin skin test administration and reading.

Moayedi-Nia S, Barss L, Oxlade O, Valiquette C, Ly MX, Campbell JR, Lan Z, Nsengiyumva P, Fregonese F, Lisboa Bastos M, Sampath D, Winters N, Menzies D.

PLoS One. 2019 Apr 17;14(4):e0215240. doi: 10.1371/journal.pone.0215240. eCollection 2019.

9.

Enhancing the public health impact of latent tuberculosis infection diagnosis and treatment (ACT4): protocol for a cluster randomised trial.

Oxlade O, Trajman A, Benedetti A, Adjobimey M, Cook VJ, Fisher D, Fox GJ, Fregonese F, Hadisoemarto P, Hill PC, Johnston J, Long R, Obeng J, Ruslami R, Valiquette C, Menzies D.

BMJ Open. 2019 Mar 20;9(3):e025831. doi: 10.1136/bmjopen-2018-025831.

10.

Is there a fundamental flaw in Canada's post-arrival immigrant surveillance system for tuberculosis?

Long R, Asadi L, Heffernan C, Barrie J, Winter C, Egedahl ML, Paulsen C, Kunimoto B, Menzies D.

PLoS One. 2019 Mar 8;14(3):e0212706. doi: 10.1371/journal.pone.0212706. eCollection 2019.

11.

Latent tuberculosis infection in healthcare workers in low- and middle-income countries: an updated systematic review.

Apriani L, McAllister S, Sharples K, Alisjahbana B, Ruslami R, Hill PC, Menzies D.

Eur Respir J. 2019 Apr 18;53(4). pii: 1801789. doi: 10.1183/13993003.01789-2018. Print 2019 Apr.

PMID:
30792341
12.

Intestinal dysbiosis compromises alveolar macrophage immunity to Mycobacterium tuberculosis.

Khan N, Mendonca L, Dhariwal A, Fontes G, Menzies D, Xia J, Divangahi M, King IL.

Mucosal Immunol. 2019 May;12(3):772-783. doi: 10.1038/s41385-019-0147-3. Epub 2019 Feb 19.

PMID:
30783183
13.

The impact of improved detection and treatment of isoniazid resistant tuberculosis on prevalence of multi-drug resistant tuberculosis: A modelling study.

Romanowski K, Campbell JR, Oxlade O, Fregonese F, Menzies D, Johnston JC.

PLoS One. 2019 Jan 24;14(1):e0211355. doi: 10.1371/journal.pone.0211355. eCollection 2019.

14.

Variable phenotypic expression of Apert syndrome in monozygotic twins.

Dap M, Bach-Segura P, Bertholdt C, Menzies D, Masutti JP, Klein O, Perdriolle-Galet E, Lambert L, Morel O.

Clin Case Rep. 2018 Nov 11;7(1):54-57. doi: 10.1002/ccr3.1915. eCollection 2019 Jan.

15.

What's Next for the Standard Short-Course Regimen for Treatment of Multidrug-Resistant Tuberculosis.

Campbell JR, Menzies D.

Am J Trop Med Hyg. 2019 Feb;100(2):229-230. doi: 10.4269/ajtmh.18-0985. No abstract available.

16.

New short regimens for latent tuberculosis treatment: safety first!

Menzies D, Trajman A.

Eur Respir J. 2018 Dec 20;52(6). pii: 1802180. doi: 10.1183/13993003.02180-2018. Print 2018 Dec. No abstract available.

PMID:
30573695
17.

Severe learning disabilities and consent.

Zhou AY, Tamin J, Turner S, Menzies D.

Occup Med (Lond). 2018 Nov 16;68(8):494-495. doi: 10.1093/occmed/kqy119. No abstract available.

PMID:
30445655
18.

Predicting tuberculosis relapse in patients treated with the standard 6-month regimen: an individual patient data meta-analysis.

Romanowski K, Balshaw RF, Benedetti A, Campbell JR, Menzies D, Ahmad Khan F, Johnston JC.

Thorax. 2019 Mar;74(3):291-297. doi: 10.1136/thoraxjnl-2017-211120. Epub 2018 Nov 12.

PMID:
30420407
19.

Causal inference with multiple concurrent medications: A comparison of methods and an application in multidrug-resistant tuberculosis.

Siddique AA, Schnitzer ME, Bahamyirou A, Wang G, Holtz TH, Migliori GB, Sotgiu G, Gandhi NR, Vargas MH, Menzies D, Benedetti A.

Stat Methods Med Res. 2018 Oct 31:962280218808817. doi: 10.1177/0962280218808817. [Epub ahead of print]

PMID:
30381005
20.

Using a quality improvement approach to improve care for latent tuberculosis infection.

Barss L, Menzies D.

Expert Rev Anti Infect Ther. 2018 Oct;16(10):737-747. doi: 10.1080/14787210.2018.1521269. Review.

PMID:
30318977
21.

Interventions to improve retention-in-care and treatment adherence among patients with drug-resistant tuberculosis: a systematic review.

Law S, Daftary A, O'Donnell M, Padayatchi N, Calzavara L, Menzies D.

Eur Respir J. 2019 Jan 10;53(1). pii: 1801030. doi: 10.1183/13993003.01030-2018. Print 2019 Jan.

PMID:
30309972
22.

Asthma phenotypes based on health services use for allergic diseases in a province-wide birth cohort.

Mésidor M, Benedetti A, El-Zein M, Menzies D, Parent MÉ, Rousseau MC.

Ann Allergy Asthma Immunol. 2019 Jan;122(1):50-57.e2. doi: 10.1016/j.anai.2018.09.453. Epub 2018 Sep 14.

PMID:
30223115
23.

Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis.

Collaborative Group for the Meta-Analysis of Individual Patient Data in MDR-TB treatment–2017, Ahmad N, Ahuja SD, Akkerman OW, Alffenaar JC, Anderson LF, Baghaei P, Bang D, Barry PM, Bastos ML, Behera D, Benedetti A, Bisson GP, Boeree MJ, Bonnet M, Brode SK, Brust JCM, Cai Y, Caumes E, Cegielski JP, Centis R, Chan PC, Chan ED, Chang KC, Charles M, Cirule A, Dalcolmo MP, D'Ambrosio L, de Vries G, Dheda K, Esmail A, Flood J, Fox GJ, Fréchet-Jachym M, Fregona G, Gayoso R, Gegia M, Gler MT, Gu S, Guglielmetti L, Holtz TH, Hughes J, Isaakidis P, Jarlsberg L, Kempker RR, Keshavjee S, Khan FA, Kipiani M, Koenig SP, Koh WJ, Kritski A, Kuksa L, Kvasnovsky CL, Kwak N, Lan Z, Lange C, Laniado-Laborín R, Lee M, Leimane V, Leung CC, Leung EC, Li PZ, Lowenthal P, Maciel EL, Marks SM, Mase S, Mbuagbaw L, Migliori GB, Milanov V, Miller AC, Mitnick CD, Modongo C, Mohr E, Monedero I, Nahid P, Ndjeka N, O'Donnell MR, Padayatchi N, Palmero D, Pape JW, Podewils LJ, Reynolds I, Riekstina V, Robert J, Rodriguez M, Seaworth B, Seung KJ, Schnippel K, Shim TS, Singla R, Smith SE, Sotgiu G, Sukhbaatar G, Tabarsi P, Tiberi S, Trajman A, Trieu L, Udwadia ZF, van der Werf TS, Veziris N, Viiklepp P, Vilbrun SC, Walsh K, Westenhouse J, Yew WW, Yim JJ, Zetola NM, Zignol M, Menzies D.

Lancet. 2018 Sep 8;392(10150):821-834. doi: 10.1016/S0140-6736(18)31644-1. Review.

PMID:
30215381
24.

The Demise of an Australian Physical Activity Alliance.

Reynolds R, Santhya, Menzies D.

J Phys Act Health. 2018 Oct 1;15(10):795-798. doi: 10.1123/jpah.2018-0042. Epub 2018 Aug 20.

PMID:
30122101
25.

Four Months of Rifampin or Nine Months of Isoniazid for Latent Tuberculosis in Adults.

Menzies D, Adjobimey M, Ruslami R, Trajman A, Sow O, Kim H, Obeng Baah J, Marks GB, Long R, Hoeppner V, Elwood K, Al-Jahdali H, Gninafon M, Apriani L, Koesoemadinata RC, Kritski A, Rolla V, Bah B, Camara A, Boakye I, Cook VJ, Goldberg H, Valiquette C, Hornby K, Dion MJ, Li PZ, Hill PC, Schwartzman K, Benedetti A.

N Engl J Med. 2018 Aug 2;379(5):440-453. doi: 10.1056/NEJMoa1714283.

26.

Safety and Side Effects of Rifampin versus Isoniazid in Children.

Diallo T, Adjobimey M, Ruslami R, Trajman A, Sow O, Obeng Baah J, Marks GB, Long R, Elwood K, Zielinski D, Gninafon M, Wulandari DA, Apriani L, Valiquette C, Fregonese F, Hornby K, Li PZ, Hill PC, Schwartzman K, Benedetti A, Menzies D.

N Engl J Med. 2018 Aug 2;379(5):454-463. doi: 10.1056/NEJMoa1714284.

27.

Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis.

Harausz EP, Garcia-Prats AJ, Law S, Schaaf HS, Kredo T, Seddon JA, Menzies D, Turkova A, Achar J, Amanullah F, Barry P, Becerra M, Chan ED, Chan PC, Ioana Chiotan D, Crossa A, Drobac PC, Fairlie L, Falzon D, Flood J, Gegia M, Hicks RM, Isaakidis P, Kadri SM, Kampmann B, Madhi SA, Marais E, Mariandyshev A, Méndez-Echevarría A, Moore BK, Nargiza P, Ozere I, Padayatchi N, Ur-Rehman S, Rybak N, Santiago-Garcia B, Shah NS, Sharma S, Shim TS, Skrahina A, Soriano-Arandes A, van den Boom M, van der Werf MJ, van der Werf TS, Williams B, Yablokova E, Yim JJ, Furin J, Hesseling AC; Collaborative Group for Meta-Analysis of Paediatric Individual Patient Data in MDR-TB.

PLoS Med. 2018 Jul 11;15(7):e1002591. doi: 10.1371/journal.pmed.1002591. eCollection 2018 Jul.

28.

Knowledge and perceptions of tuberculosis transmission and prevention among physicians and nurses in three Brazilian capitals with high incidence of tuberculosis.

Ramos J, Wakoff-Pereira MF, Cordeiro-Santos M, Albuquerque MFM, Hill PC, Menzies D, Trajman A.

J Bras Pneumol. 2018 Apr;44(2):168-170. doi: 10.1590/s1806-37562018000000019. English, Portuguese. No abstract available.

29.

Comparison of different treatments for isoniazid-resistant tuberculosis: an individual patient data meta-analysis.

Fregonese F, Ahuja SD, Akkerman OW, Arakaki-Sanchez D, Ayakaka I, Baghaei P, Bang D, Bastos M, Benedetti A, Bonnet M, Cattamanchi A, Cegielski P, Chien JY, Cox H, Dedicoat M, Erkens C, Escalante P, Falzon D, Garcia-Prats AJ, Gegia M, Gillespie SH, Glynn JR, Goldberg S, Griffith D, Jacobson KR, Johnston JC, Jones-López EC, Khan A, Koh WJ, Kritski A, Lan ZY, Lee JH, Li PZ, Maciel EL, Galliez RM, Merle CSC, Munang M, Narendran G, Nguyen VN, Nunn A, Ohkado A, Park JS, Phillips PPJ, Ponnuraja C, Reves R, Romanowski K, Seung K, Schaaf HS, Skrahina A, Soolingen DV, Tabarsi P, Trajman A, Trieu L, Banurekha VV, Viiklepp P, Wang JY, Yoshiyama T, Menzies D.

Lancet Respir Med. 2018 Apr;6(4):265-275. doi: 10.1016/S2213-2600(18)30078-X. Erratum in: Lancet Respir Med. 2018 Apr 18;:.

PMID:
29595509
30.

Determinants of tuberculosis trends in six Indigenous populations of the USA, Canada, and Greenland from 1960 to 2014: a population-based study.

Dehghani K, Lan Z, Li P, Michelsen SW, Waites S, Benedetti A, Lejeune P, Torrie J, Robinson E, Vejvoda B, Mullah M, Redwood D, Cooper M, Fanning A, Yacoub W, Alvarez GG, Søborg B, Long R, Menzies D.

Lancet Public Health. 2018 Mar;3(3):e133-e142. doi: 10.1016/S2468-2667(18)30002-1. Epub 2018 Feb 14.

31.

Effectiveness of Canada's tuberculosis surveillance strategy in identifying immigrants at risk of developing and transmitting tuberculosis: a population-based retrospective cohort study.

Asadi L, Heffernan C, Menzies D, Long R.

Lancet Public Health. 2017 Oct;2(10):e450-e457. doi: 10.1016/S2468-2667(17)30161-5. Epub 2017 Oct 3.

32.

Emergence of drug resistance in patients with tuberculosis cared for by the Indian health-care system: a dynamic modelling study.

Law S, Piatek AS, Vincent C, Oxlade O, Menzies D.

Lancet Public Health. 2017 Jan;2(1):e47-e55. doi: 10.1016/S2468-2667(16)30035-4. Epub 2016 Dec 19.

33.

Correction: The impact of the Brazilian family health on selected primary care sensitive conditions: A systematic review.

Bastos ML, Menzies D, Hone T, Dehghani K, Trajman A.

PLoS One. 2017 Dec 7;12(12):e0189557. doi: 10.1371/journal.pone.0189557. eCollection 2017.

34.

Tuberculosis transmission in the Indigenous peoples of the Canadian prairies.

Patel S, Paulsen C, Heffernan C, Saunders D, Sharma M, King M, Hoeppner V, Orr P, Kunimoto D, Menzies D, Christianson S, Wolfe J, Boffa J, McMullin K, Lopez-Hille C, Senthilselvan A, Long R.

PLoS One. 2017 Nov 14;12(11):e0188189. doi: 10.1371/journal.pone.0188189. eCollection 2017.

35.

Reply to Dobler.

Greenaway C, Shrier I, Abou Chakra CN, Cnossen S, Cheng MP, Yansouni CP, Menzies D.

Clin Infect Dis. 2017 Oct 15;65(8):1423-1424. doi: 10.1093/cid/cix521. No abstract available.

PMID:
29017250
36.

Knowledge about tuberculosis transmission and prevention and perceptions of health service utilization among index cases and contacts in Brazil: Understanding losses in the latent tuberculosis cascade of care.

Salame FM, Ferreira MD, Belo MT, Teixeira EG, Cordeiro-Santos M, Ximenes RA, de Albuquerque MFM, Hill PC, Menzies D, Trajman A.

PLoS One. 2017 Sep 21;12(9):e0184061. doi: 10.1371/journal.pone.0184061. eCollection 2017.

37.

The shifting paradigm in the treatment of type 2 diabetes mellitus-A cardiologist's perspective.

Fatima S, Jameel A, Ayesha F, Menzies DJ.

Clin Cardiol. 2017 Nov;40(11):970-973. doi: 10.1002/clc.22781. Epub 2017 Aug 25. Review.

38.

The impact of the Brazilian family health strategy on selected primary care sensitive conditions: A systematic review.

Bastos ML, Menzies D, Hone T, Dehghani K, Trajman A.

PLoS One. 2017 Aug 7;12(8):e0182336. doi: 10.1371/journal.pone.0182336. eCollection 2017. Review. Erratum in: PLoS One. 2017 Dec 7;12 (12 ):e0189557.

39.

Effectiveness and safety of standardised shorter regimens for multidrug-resistant tuberculosis: individual patient data and aggregate data meta-analyses.

Ahmad Khan F, Salim MAH, du Cros P, Casas EC, Khamraev A, Sikhondze W, Benedetti A, Bastos M, Lan Z, Jaramillo E, Falzon D, Menzies D.

Eur Respir J. 2017 Jul 27;50(1). pii: 1700061. doi: 10.1183/13993003.00061-2017. Print 2017 Jul.

40.

Bacillus Calmette-Guérin (BCG) vaccination patterns in the province of Québec, Canada, 1956-1974.

Rousseau MC, Conus F, Kâ K, El-Zein M, Parent MÉ, Menzies D.

Vaccine. 2017 Aug 24;35(36):4777-4784. doi: 10.1016/j.vaccine.2017.06.064. Epub 2017 Jul 10.

41.

Facilitators of Attendance and Adherence to Group-Based Physical Activity for Older Adults: A Literature Synthesis.

de Lacy-Vawdon CJ, Klein R, Schwarzman J, Nolan G, de Silva R, Menzies D, Smith BJ.

J Aging Phys Act. 2018 Jan 1;26(1):155-167. doi: 10.1123/japa.2016-0363. Epub 2017 Nov 30. Review.

PMID:
28595021
42.

Association Between Bacillus Calmette-Guérin Vaccination and Childhood Asthma in the Quebec Birth Cohort on Immunity and Health.

El-Zein M, Conus F, Benedetti A, Menzies D, Parent ME, Rousseau MC.

Am J Epidemiol. 2017 Aug 1;186(3):344-355. doi: 10.1093/aje/kwx088.

43.

Validated methods for identifying tuberculosis patients in health administrative databases: systematic review.

Ronald LA, Ling DI, FitzGerald JM, Schwartzman K, Bartlett-Esquilant G, Boivin JF, Benedetti A, Menzies D.

Int J Tuberc Lung Dis. 2017 May 1;21(5):517-522. doi: 10.5588/ijtld.16.0588. Review.

PMID:
28399966
44.

The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis.

Dheda K, Gumbo T, Maartens G, Dooley KE, McNerney R, Murray M, Furin J, Nardell EA, London L, Lessem E, Theron G, van Helden P, Niemann S, Merker M, Dowdy D, Van Rie A, Siu GK, Pasipanodya JG, Rodrigues C, Clark TG, Sirgel FA, Esmail A, Lin HH, Atre SR, Schaaf HS, Chang KC, Lange C, Nahid P, Udwadia ZF, Horsburgh CR Jr, Churchyard GJ, Menzies D, Hesseling AC, Nuermberger E, McIlleron H, Fennelly KP, Goemaere E, Jaramillo E, Low M, Jara CM, Padayatchi N, Warren RM.

Lancet Respir Med. 2017 Mar 15. pii: S2213-2600(17)30079-6. doi: 10.1016/S2213-2600(17)30079-6. [Epub ahead of print] Review.

PMID:
28344011
45.

An updated systematic review and meta-analysis for treatment of multidrug-resistant tuberculosis.

Bastos ML, Lan Z, Menzies D.

Eur Respir J. 2017 Mar 22;49(3). pii: 1600803. doi: 10.1183/13993003.00803-2016. Print 2017 Mar. Review.

46.

Isoniazid-resistant tuberculosis treatment with first-line drugs-Author reply.

Menzies D.

Lancet Infect Dis. 2017 Mar;17(3):260. doi: 10.1016/S1473-3099(17)30077-4. Epub 2017 Feb 23. No abstract available.

PMID:
28244386
47.

Latent tuberculous infection in household contacts of multidrug-resistant and newly diagnosed tuberculosis.

Fox GJ, Anh NT, Nhung NV, Loi NT, Hoa NB, Ngoc Anh LT, Cuong NK, Buu TN, Marks GB, Menzies D.

Int J Tuberc Lung Dis. 2017 Mar 1;21(3):297-302. doi: 10.5588/ijtld.16.0576.

PMID:
28225339
48.

Effect of Intermittency on Treatment Outcomes in Pulmonary Tuberculosis: An Updated Systematic Review and Metaanalysis.

Johnston JC, Campbell JR, Menzies D.

Clin Infect Dis. 2017 May 1;64(9):1211-1220. doi: 10.1093/cid/cix121. Review.

PMID:
28203783
49.

Finding the right dose of rifampicin, and the right dose of optimism.

Ruslami R, Menzies D.

Lancet Infect Dis. 2017 Jan;17(1):2-3. doi: 10.1016/S1473-3099(16)30315-2. Epub 2016 Oct 26. No abstract available.

50.

Group 5 drugs for multidrug-resistant tuberculosis: individual patient data meta-analysis.

Fox GJ, Benedetti A, Cox H, Koh WJ, Viiklepp P, Ahuja S, Pasvol G, Menzies D; Collaborative Group for Meta-Analysis of Individual Patient Data in MDR-TB.

Eur Respir J. 2017 Jan 3;49(1). pii: 1600993. doi: 10.1183/13993003.00993-2016. Print 2017 Jan.

Supplemental Content

Loading ...
Support Center